P931_CLYBL-CBX3-Cbh-Zeo-TetO-NAIP2
(Plasmid
#202761)
-
PurposeEncodes four RGC specific transcription factors under the control of a TetOn promoter at the CLYBL safe harbor
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 202761 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepUC19
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNEUROG2-p2A-ATOH7-p2A-ISL1-p2A-POU4F2
-
Alt nameNAIP2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)3747
-
Entrez GeneNEUROG2 (a.k.a. Atoh4, Math4A, NGN2, bHLHa8, ngn-2)
-
Entrez GeneATOH7 (a.k.a. Math5, NCRNA, PHPVAR, RNANC, bHLHa13)
-
Entrez GeneISL1 (a.k.a. ISLET1, Isl-1)
-
Entrez GenePOU4F2 (a.k.a. BRN3.2, BRN3B, Brn-3b)
- Promoter TetO
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer GCTCGTTTAGTGAACCGTCAG (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
P931_CLYBL-CBX3-Cbh-Zeo-TetO-NAIP2 was a gift from Karl Wahlin (Addgene plasmid # 202761 ; http://n2t.net/addgene:202761 ; RRID:Addgene_202761) -
For your References section:
Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming. Agarwal D, Dash N, Mazo KW, Chopra M, Avila MP, Patel A, Wong RM, Jia C, Do H, Cheng J, Chiang C, Jurlina SL, Roshan M, Perry MW, Rho JM, Broyer R, Lee CD, Weinreb RN, Gavrilovici C, Oesch NW, Welsbie DS, Wahlin KJ. NPJ Regen Med. 2023 Sep 29;8(1):55. doi: 10.1038/s41536-023-00327-x. 10.1038/s41536-023-00327-x PubMed 37773257